Research Article
Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy
Table 1
Patient’s characteristics and treatment details.
| | | All patients | Conv-rad | IMRT/IGRT | | = (%) | = (%) | = (%) |
| | Age | | | | | Median | 64 (40–77) | 65 (53–77) | 62 (40–74) | | ♀/♂ | 15/7 (68/32) | 5/1 (83/17) | 10/6 (62.5/37.5) | | Previous resection | | | | | Yes/no | 10/12 (45/55) | 4/2 (67/33) | 8/8 (50/50) | | Tumor localisation | | | | | Pancreatic head | 16 (73) | 4 (67) | 11 (69) | | Body | 5 (22) | 1 (17) | 4 (25) | | Tail | 1 (5) | 1 (17) | 1 (6) | | Radiation therapy | | | | | Alone | 10 (45) | 4 (67) | 6 (37.5) | | With chemotherapy | 12 (55) | 2 (33) | 10 (62.5) | | 3D conformal | 6 (27) | 6 (100) | — | | IMRT/IGRT | 16 (73) | — | 16 (100) | | Preradiation chem | | | | | GemMono | 20 (91) | 5 (83) | 15 (94) | | GemCombination | 2 (9) | 1 (17) | 1 (6) | | >1 therapy | 5 (22) | 3 (50) | 2 (13) | | Duration preradiation chemotherapy | | | | | 3–6 months | 3 (14) | 0 | 3 (19) | | 6–9 months | 6 (27) | 2 (33) | 4 (25) | | 9–12 months | 3 (14) | 1 (17) | 2 (12) | | >12 months | 10 (45) | 3 (50) | 7 (44) |
|
|
